Inflammatory Bowel Disease

Patients who underwent vagotomy were at greater risk for later development of inflammatory bowel disease, indicating the beneficial role of the vagal tone in IBD, according to research published in Alimentary Pharmacology & Therapeutics.

The first COVID-19 related story concerned with gastroenterology was published in Healio Gastroenterology and Liver Disease on March 6. Since then, we have published more than a dozen articles and posted numerous videos from leaders in the GI community about how the pandemic has impacted clinical practice and how it might change things going forward.

Treatment with dual biologic therapy was associated with clinical and endoscopic improvements in patients with Crohn’s disease who previously failed multiple biologics, according to study results.

During this COVID-19 pandemic, many scientists have turned their efforts to find either a treatment or vaccine for the infection or trying to better understand the infection.

Identifying which patients respond quickly to dietary therapies for Crohn’s disease may help indicate which ones will succeed long term and which ones might do better on a different therapy, according to study results.

Patients with both chronic inflammatory disease and inflammatory bowel disease demonstrated higher health use and costs, compared with those with just chronic inflammatory disease, according to data published in BMC Rheumatology.

Real-world data from a multicenter study revealed that Stelara helped patients with ulcerative colitis achieve steroid-free remission, according to research published in Alimentary Pharmacology & Therapeutics.

The American Gastroenterological Association issued new guidance for the clinical management of patients with inflammatory bowel disease during the COVID-19 pandemic.

In this exclusive video series, Stephen B. Hanauer, MD, medical director of the Digestive Health Center at Northwestern University Feinberg School of Medicine, discusses the impact of COVID-19 on the world of gastroenterology. In this video, he told Healio Gastroenterology and Liver Disease about how it has affected patients with inflammatory bowel disease, as well as clinical trials.

As COVID-19 continues to spread, gastroenterologists are assessing how the virus impacts patients with inflammatory bowel disease.